This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. shed 5.8% to $2.12 on what proved to be an all-around rough trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 42,865.77 and the NASDAQ Composite Index falling 0.5% to 19,615.88.
Inovio Pharmaceuticals Inc. closed 82.8% short of its 52-week high of $12.33, which the company reached on July 26th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson fell 0.8% to $155.26, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.74% to $24.48.
Trading volume totaled 824,823, compared to the 50-day average of 625,332.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 11, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.